Showing 1 - 1 results of 1 for search 'Paul Dent', query time: 0.01s Refine Results
  1. 1
    Neratinib as a Potential Therapeutic for Mutant RAS and Osimertinib-Resistant Tumours

    Neratinib as a Potential Therapeutic for Mutant RAS and Osimertinib-Resistant Tumours by Paul Dent, Laurence Booth, Andrew Poklepovic, John F. Hancock

    Published 2022-09-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: